Séverine Valmary1, Peter Dorfmüller2, David Montani2, Marc Humbert2, Pierre Brousset3, Bruno Degano4. 1. Service d'Anatomie Pathologique and INSERM U563, Centre Hospitalier Universitaire Purpan, Toulouse; Service d'Anatomie Pathologique, Centre Hospitalier Universitaire Jean Minjoz, Besançon. 2. INSERM U999, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Centre Chirurgical Marie-Lannelongue, Le Plessis-Robinson; AP-HP, Service de Pneumologie et Réanimation Respiratoire, Centre National de Référence de l'Hypertension Pulmonaire Sévère, Hôpital Antoine Béclère, Clamart; Université Paris-Sud, Faculté de médecine, Kremlin Bicêtre, France. 3. Service d'Anatomie Pathologique and INSERM U563, Centre Hospitalier Universitaire Purpan, Toulouse. 4. Service d'Explorations Fonctionnelles-Physiologie et EA 3920, Centre Hospitalier Universitaire Jean Minjoz, Besançon; INSERM U999, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Centre Chirurgical Marie-Lannelongue, Le Plessis-Robinson; AP-HP, Service de Pneumologie et Réanimation Respiratoire, Centre National de Référence de l'Hypertension Pulmonaire Sévère, Hôpital Antoine Béclère, Clamart. Electronic address: bruno.degano@univ-fcomte.fr.
Abstract
BACKGROUND: In susceptible individuals, multiple events may trigger pulmonary vascular remodeling and pulmonary arterial hypertension (PAH). Human herpesvirus-8 (HHV-8), a γ-herpesvirus homologous with Epstein-Barr virus (EBV), was suggested to act as a "second hit" in the development of PAH in susceptible patients. Although there is indirect evidence from in vitro and animal studies in favor of a link between γ-herpesviruses and the pathophysiology of PAH, results remain controversial. Therefore, we investigated the presence of EBV and HHV-8 in the lungs of patients with PAH. METHODS: Thirty-four lungs explanted from French patients with end-stage PAH (mean age, 38 ± 14 years; 19 women) were studied. Tissue samples were incorporated into tissue microarrays. Normal lung tissues served as negative controls. Kaposi sarcoma tissue served as a positive control for HHV-8, and EBV-associated lymphoma served as a positive control for EBV. The presence of HHV-8 was investigated with immunohistochemistry and polymerase chain reaction. The presence of EBV was investigated with immunohistochemistry and in situ hybridization. RESULTS: For HHV-8, none of PAH lung samples showed a "stippling" nuclear pattern classically observed in HHV-8-positive Kaposi sarcoma lesions. When studied by polymerase chain reaction, all cases remained negative. For EBV, none of the PAH lung samples showed positive staining, whatever the technique applied. CONCLUSIONS: HHV-8 and EBV cannot be detected in the lungs of patients with end-stage PAH. The role of these γ-herpesviruses in the pathophysiology of PAH is, therefore, unlikely.
BACKGROUND: In susceptible individuals, multiple events may trigger pulmonary vascular remodeling and pulmonary arterial hypertension (PAH). Human herpesvirus-8 (HHV-8), a γ-herpesvirus homologous with Epstein-Barr virus (EBV), was suggested to act as a "second hit" in the development of PAH in susceptible patients. Although there is indirect evidence from in vitro and animal studies in favor of a link between γ-herpesviruses and the pathophysiology of PAH, results remain controversial. Therefore, we investigated the presence of EBV and HHV-8 in the lungs of patients with PAH. METHODS: Thirty-four lungs explanted from French patients with end-stage PAH (mean age, 38 ± 14 years; 19 women) were studied. Tissue samples were incorporated into tissue microarrays. Normal lung tissues served as negative controls. Kaposi sarcoma tissue served as a positive control for HHV-8, and EBV-associated lymphoma served as a positive control for EBV. The presence of HHV-8 was investigated with immunohistochemistry and polymerase chain reaction. The presence of EBV was investigated with immunohistochemistry and in situ hybridization. RESULTS: For HHV-8, none of PAH lung samples showed a "stippling" nuclear pattern classically observed in HHV-8-positive Kaposi sarcoma lesions. When studied by polymerase chain reaction, all cases remained negative. For EBV, none of the PAH lung samples showed positive staining, whatever the technique applied. CONCLUSIONS:HHV-8 and EBV cannot be detected in the lungs of patients with end-stage PAH. The role of these γ-herpesviruses in the pathophysiology of PAH is, therefore, unlikely.
Authors: Toshie Saito; Kazuya Miyagawa; Shih-Yu Chen; Rasa Tamosiuniene; Lingli Wang; Orr Sharpe; Erik Samayoa; Daisuke Harada; Jan-Renier A J Moonen; Aiqin Cao; Pin-I Chen; Jan K Hennigs; Mingxia Gu; Caiyun G Li; Ryan D Leib; Dan Li; Christopher M Adams; Patricia A Del Rosario; Matthew Bill; Francois Haddad; Jose G Montoya; William H Robinson; Wendy J Fantl; Garry P Nolan; Roham T Zamanian; Mark R Nicolls; Charles Y Chiu; Maria E Ariza; Marlene Rabinovitch Journal: Circulation Date: 2017-09-21 Impact factor: 29.690
Authors: Michał Tomaszewski; Ewelina Grywalska; Andrzej Tomaszewski; Piotr Błaszczak; Marcin Kurzyna; Jacek Roliński; Grzegorz Kopeć Journal: J Clin Med Date: 2020-06-24 Impact factor: 4.241